Clinical Trial Update: CSF Proteomic Characterization of Glioblastomas

View source ↗

Summary

A CSF proteomic characterization study in glioblastoma is listed, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Univeridad Autonoma de Guadalajara | Conditions: Glioblastoma, Glioblastoma WHO Grade IV | Status: NOT_YET_RECRUITING